RNA疫苗-话题@MedSci

#RNA疫苗#

127篇内容 | 3090人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1947426, encodeId=30d2194e42670, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nature：诺奖级mRNA疫苗发展史中，数百位研究人员谁是重要的贡献者？, objectType=article, longId=217652, objectId=721e21e65203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721e21e65203, replyNumber=0, likeNumber=110, createdTime=2022-03-25, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721e21e65203, moduleTitle=Nature：诺奖级mRNA疫苗发展史中，数百位研究人员谁是重要的贡献者？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=721e21e65203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947444, encodeId=7fc4194e4449f, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗, objectType=article, longId=221455, objectId=364e221455fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e221455fb, replyNumber=0, likeNumber=90, createdTime=2022-04-17, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e221455fb, moduleTitle=NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e221455fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947432, encodeId=d687194e4321d, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2021年10月12日简报：灭活疫苗接种后、以mRNA疫苗加强接种，中和抗体提升46.6倍；日本新冠疫情“退潮”令专家困惑；全国累计报告接种新冠疫苗22.2亿剂次, objectType=article, longId=218460, objectId=db3321846045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db3321846045, replyNumber=0, likeNumber=83, createdTime=2022-03-09, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db3321846045, moduleTitle=2021年10月12日简报：灭活疫苗接种后、以mRNA疫苗加强接种，中和抗体提升46.6倍；日本新冠疫情“退潮”令专家困惑；全国累计报告接种新冠疫苗22.2亿剂次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db3321846045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947403, encodeId=64ac194e40334, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=国内**mRNA疫苗即将获批，超级抗体可中和多种冠状病毒 | 新冠研究一周进展, objectType=article, longId=214619, objectId=b1fa21461954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1fa21461954, replyNumber=0, likeNumber=69, createdTime=2022-05-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1fa21461954, moduleTitle=国内**mRNA疫苗即将获批，超级抗体可中和多种冠状病毒 | 新冠研究一周进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1fa21461954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947467, encodeId=3ff3194e46748, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Ann Rheum Dis：自身免疫性风湿病患者能接种COVID-19 mRNA疫苗BNT162b2和加强针吗？, objectType=article, longId=724837, objectId=e975e24837b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e975e24837b2, replyNumber=0, likeNumber=83, createdTime=2022-11-11, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e975e24837b2, moduleTitle=Ann Rheum Dis：自身免疫性风湿病患者能接种COVID-19 mRNA疫苗BNT162b2和加强针吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e975e24837b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947457, encodeId=bbe3194e457e1, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=科普：辉瑞mRNA疫苗（复必泰）不安全吗？谣言的来龙去脉！, objectType=article, longId=300873, objectId=ac0c3008e322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0c3008e322, replyNumber=0, likeNumber=125, createdTime=2022-11-09, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0c3008e322, moduleTitle=科普：辉瑞mRNA疫苗（复必泰）不安全吗？谣言的来龙去脉！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac0c3008e322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947454, encodeId=552b194e454f3, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=感染者面临较高的抑郁风险，首款可室温保存的mRNA疫苗问世丨新冠研究一周进展, objectType=article, longId=299282, objectId=0c19299282bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c19299282bd, replyNumber=0, likeNumber=73, createdTime=2022-09-23, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c19299282bd, moduleTitle=感染者面临较高的抑郁风险，首款可室温保存的mRNA疫苗问世丨新冠研究一周进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c19299282bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947404, encodeId=89e6194e4045a, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系, objectType=article, longId=214781, objectId=9624214e8127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9624214e8127, replyNumber=0, likeNumber=71, createdTime=2021-09-11, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9624214e8127, moduleTitle=mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9624214e8127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947412, encodeId=3685194e4127f, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：mRNA疫苗和腺病毒疫苗对德尔塔突变株的保护效率下降, objectType=article, longId=215970, objectId=6e4a2159e05d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4a2159e05d, replyNumber=0, likeNumber=102, createdTime=2021-09-03, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4a2159e05d, moduleTitle=NEJM：mRNA疫苗和腺病毒疫苗对德尔塔突变株的保护效率下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e4a2159e05d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947414, encodeId=6890194e4148c, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=美国FDA全面批准辉瑞BioNTech新冠mRNA疫苗，美军将全员接种, objectType=article, longId=216255, objectId=a27c21625501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a27c21625501, replyNumber=0, likeNumber=58, createdTime=2021-12-02, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a27c21625501, moduleTitle=美国FDA全面批准辉瑞BioNTech新冠mRNA疫苗，美军将全员接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a27c21625501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947463, encodeId=bdef194e46354, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=AI赋能加速mRNA疫苗和药物研发, objectType=article, longId=300999, objectId=79f4300999e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f4300999e6, replyNumber=0, likeNumber=77, createdTime=2022-04-06, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f4300999e6, moduleTitle=AI赋能加速mRNA疫苗和药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f4300999e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947415, encodeId=5ca7194e415c4, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2021年8月25日简报：全球新冠疫苗接种超50亿剂次，多位反疫苗明星因感染新冠去世，国内mRNA疫苗可能很快上市, objectType=article, longId=216290, objectId=8559216290a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8559216290a6, replyNumber=0, likeNumber=58, createdTime=2021-08-31, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8559216290a6, moduleTitle=2021年8月25日简报：全球新冠疫苗接种超50亿剂次，多位反疫苗明星因感染新冠去世，国内mRNA疫苗可能很快上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8559216290a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947437, encodeId=2ee5194e437e5, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：接种BNT162b2 mRNA疫苗6个月内的安全性和效果分析, objectType=article, longId=219800, objectId=9c81219800bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c81219800bb, replyNumber=0, likeNumber=76, createdTime=2022-08-16, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c81219800bb, moduleTitle=NEJM：接种BNT162b2 mRNA疫苗6个月内的安全性和效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c81219800bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947443, encodeId=3f62194e443dd, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=BMJ：mRNA疫苗接种后90天可考虑接种“第三针”, objectType=article, longId=221407, objectId=cce222140e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce222140e0a, replyNumber=0, likeNumber=108, createdTime=2022-07-08, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce222140e0a, moduleTitle=BMJ：mRNA疫苗接种后90天可考虑接种“第三针”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cce222140e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947397, encodeId=f675194e3979d, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=mRNA疫苗同罕见心肌炎之间可能存在关联, objectType=article, longId=213421, objectId=ff61213421e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff61213421e4, replyNumber=0, likeNumber=66, createdTime=2022-01-03, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff61213421e4, moduleTitle=mRNA疫苗同罕见心肌炎之间可能存在关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff61213421e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947391, encodeId=0870194e39141, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=美国CDC将召开紧急会议，讨论接mRNA疫苗或致心脏炎症病例, objectType=article, longId=212654, objectId=64c32126547f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c32126547f, replyNumber=0, likeNumber=86, createdTime=2021-11-03, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c32126547f, moduleTitle=美国CDC将召开紧急会议，讨论接mRNA疫苗或致心脏炎症病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c32126547f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947436, encodeId=a1de194e436af, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2021年10月27日简报：本土散发病例超10个省市；国际多国为3-11岁儿童接种中国新冠疫苗；mRNA疫苗寻求为儿童接种, objectType=article, longId=219332, objectId=e56d21933234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56d21933234, replyNumber=0, likeNumber=67, createdTime=2022-05-11, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56d21933234, moduleTitle=2021年10月27日简报：本土散发病例超10个省市；国际多国为3-11岁儿童接种中国新冠疫苗；mRNA疫苗寻求为儿童接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56d21933234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947439, encodeId=625e194e4397a, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=JAMA：因心脏副作用，德国建议30岁以下的人不要打Moderna的mRNA疫苗, objectType=article, longId=220384, objectId=cd3a220384f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd3a220384f9, replyNumber=0, likeNumber=52, createdTime=2022-06-01, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd3a220384f9, moduleTitle=JAMA：因心脏副作用，德国建议30岁以下的人不要打Moderna的mRNA疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd3a220384f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947393, encodeId=51a8194e39370, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nat Med：旧伤未愈又添新伤，BNT162b2-mRNA疫苗接种个体中SARS-CoV-2变异的突破率增加, objectType=article, longId=212829, objectId=796321282910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796321282910, replyNumber=0, likeNumber=58, createdTime=2021-10-16, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796321282910, moduleTitle=Nat Med：旧伤未愈又添新伤，BNT162b2-mRNA疫苗接种个体中SARS-CoV-2变异的突破率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=796321282910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947402, encodeId=3097194e40249, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nature：BNT162b2 mRNA疫苗在人群中的表现到底如何？, objectType=article, longId=214147, objectId=b56621414ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b56621414ed9, replyNumber=0, likeNumber=60, createdTime=2022-06-20, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b56621414ed9, moduleTitle=Nature：BNT162b2 mRNA疫苗在人群中的表现到底如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b56621414ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RNA疫苗

2020-05-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nature：诺奖级mRNA疫苗发展史中，数百位研究人员谁是重要的贡献者？

2022-03-25

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗

2022-04-17

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2021年10月12日简报：灭活疫苗接种后、以mRNA疫苗加强接种，中和抗体提升46.6倍；日本新冠疫情“退潮”令专家困惑；全国累计报告接种新冠疫苗22.2亿剂次

2022-03-09

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

国内**mRNA疫苗即将获批，超级抗体可中和多种冠状病毒 | 新冠研究一周进展

2022-05-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Ann Rheum Dis：自身免疫性风湿病患者能接种COVID-19 mRNA疫苗BNT162b2和加强针吗？

2022-11-11

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

科普：辉瑞mRNA疫苗（复必泰）不安全吗？谣言的来龙去脉！

2022-11-09

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

感染者面临较高的抑郁风险，首款可室温保存的mRNA疫苗问世丨新冠研究一周进展

2022-09-23

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系

2021-09-11

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：mRNA疫苗和腺病毒疫苗对德尔塔突变株的保护效率下降

2021-09-03

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

美国FDA全面批准辉瑞BioNTech新冠mRNA疫苗，美军将全员接种

2021-12-02

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

AI赋能加速mRNA疫苗和药物研发

2022-04-06

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2021年8月25日简报：全球新冠疫苗接种超50亿剂次，多位反疫苗明星因感染新冠去世，国内mRNA疫苗可能很快上市

2021-08-31

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：接种BNT162b2 mRNA疫苗6个月内的安全性和效果分析

2022-08-16

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

BMJ：mRNA疫苗接种后90天可考虑接种“第三针”

2022-07-08

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

mRNA疫苗同罕见心肌炎之间可能存在关联

2022-01-03

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

美国CDC将召开紧急会议，讨论接mRNA疫苗或致心脏炎症病例

2021-11-03

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2021年10月27日简报：本土散发病例超10个省市；国际多国为3-11岁儿童接种中国新冠疫苗；mRNA疫苗寻求为儿童接种

2022-05-11

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

JAMA：因心脏副作用，德国建议30岁以下的人不要打Moderna的mRNA疫苗

2022-06-01

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nat Med：旧伤未愈又添新伤，BNT162b2-mRNA疫苗接种个体中SARS-CoV-2变异的突破率增加

2021-10-16

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nature：BNT162b2 mRNA疫苗在人群中的表现到底如何？

2022-06-20

科室
- - 订阅+
  - 更多科室
工具
服务